Evidence map›Paper›PMID 31952230›Full record

ArticleJournal of clinical medicine2020

Induction of HO-1 by Mevastatin Mediated via a Nox/ROS-Dependent c-Src/PDGFRα/PI3K/Akt/Nrf2/ARE Cascade Suppresses TNF-α-Induced Lung Inflammation.

Chih-Chung Lin, Wei-Ning Lin, Rou-Ling Cho, Chien-Chung Yang, Yi-Cheng Yeh, Li-Der Hsiao, Hui-Ching Tseng, Chuen-Mao Yang

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. 5,8-Dihydroxy-4 ', 7-dimethoxyflavone Attenuates TNF-Oxidative medicine and cellular longevity · 2022
    Article
  11. p47Antioxidants (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Chih-Chung LinDepartment of Anesthetics, Chang Gung Memorial Hospital at Linkuo, Kwei-San, Tao-Yuan 33302, Taiwan.
Wei-Ning LinGraduate Institution of Biomedical and Pharmaceutical Science, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.ORCID 0000-0003-3205-871X
Rou-Ling ChoDepartment of Pharmacology, College of Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0002-8970-5562
Chien-Chung YangDepartment of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Tao-Yuan, Kwei-San, Tao-Yuan 33302, Taiwan.
Yi-Cheng YehDepartment of Pharmacology, College of Medicine, China Medical University, Taichung 40402, Taiwan.
Li-Der HsiaoDepartment of Pharmacology, College of Medicine, China Medical University, Taichung 40402, Taiwan.
Hui-Ching TsengDepartment of Pharmacology, College of Medicine, China Medical University, Taichung 40402, Taiwan.
Chuen-Mao YangDepartment of Pharmacology, College of Medicine, China Medical University, Taichung 40402, Taiwan.
Asia University · TWChina Medical University · TWChang Gung Memorial Hospital · TWFu Jen Catholic University · TW

Funding

Chang Gung Medical Foundation CMRPD1I0051-3Chang Gung Medical Foundation CMRPG3H0062Chang Gung Medical Foundation CMRPG3H0063Chang Gung Medical Foundation CMRPG5F0203Chang Gung Medical Foundation CMRPG5I0041Chang Gung University CMRPG3F1533China Medical University, Taiwan CMU108-MF-08Ministry of Science and Technology, Taiwan MOST105-2320-B-182-005-MY3Ministry of Science and Technology, Taiwan MOST107-2320-B-182-020-MY2Ministry of Science and Technology, Taiwan MOST108-2320-B-039-061Ministry of Science and Technology, Taiwan MOST108-2320-B-182-014
6 · The paper itself

Abstract

backgroundMevastatin (MVS), a 3-hydroxy-3-methylglutaryl coenzyme, a reductase (HMG-CoA) inhibitor, has anti-inflammatory effects potentially via up-regulation of heme oxygenase-1 (HO-1). However, the mechanisms underlying MVS-induced HO-1 expression remain largely unknown in human pulmonary alveolar epithelial cells (HPAEpiCs).

methodsHO-1 and intercellular adhesion molecule (ICAM)-1 expression were determined using real-time PCR, Western blotting, and promoter reporter analyses. The signaling components were investigated using pharmacological inhibitors or specific small interfering RNA (siRNA)s. Interaction between Nrf2 and the antioxidant response element (ARE) binding site for the HO-1 promoter was determined by chromatin immunoprecipitation (ChIP) assay.

resultsUpregulation of HO-1 by MVS attenuated the tumor necrosis factor (TNF)-α-stimulated ICAM-1 expression associated with THP-1 adhesion to HPAEpiCs. These inhibitory effects of HO-1 were reversed by tin protoporphyrin (SnPP)IX or by transfection with HO-1 siRNA. MVS-induced HO-1 expression was mediated via NADPH oxidase (Nox)-derived reactive oxygen species (ROS) generation. Activation of Nox2/ROS further stimulated the phosphorylation of p47

conclusionsMVS-induced HO-1 is, at least in part, mediated through a p47

Indexed as

AREsheme oxygenase-1mevastatinNrf2ROS

Identifiers

PMID31952230
PMCPMC7019964
OpenAlexW2999333853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.